Biote Corp (BTMD)

$2.58 +0.05 (1.98%)
Market Cap 111.87M
Revenue (ttm) 197.19M
Net Income (ttm) 3.16M
EPS (ttm) N/A
PE Ratio 5.08
Forward PE 8.19
Profit Margin 1.60%
Debt to Equity Ratio -1.58
Volume 125,272
Avg Vol 140,146
Day's Range N/A - N/A
Shares Out 45.66M
Stochastic %K 38%
Beta 1.16
Analysts Strong Sell
Price Target $4.51

Company Profile

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method...

Industry: Medical Care Facilities
Sector: Healthcare
Phone: 844 604 1246
Address:
1875 W. Walnut Hill Ln #100, Irving, United States
Shadetreeengineer
Shadetreeengineer Jan. 7 at 3:54 PM
$BTMD added to position
1 · Reply
CapnKrunch
CapnKrunch Jan. 2 at 3:40 PM
$BTMD This stock is hot garbage!
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 23 at 8:28 PM
$BTMD
0 · Reply
convicente
convicente Dec. 22 at 4:42 PM
$PFE $MRNA looks like biote is about to run $BTMD
0 · Reply
convicente
convicente Dec. 19 at 7:29 PM
$CGC i am out of this one. Tilray got me already in the past with RS. This one isn't going to catch me again. To much exposure in the same industry. Just entered $BTMD hormon industry
0 · Reply
convicente
convicente Dec. 19 at 6:19 PM
$BTMD looks Great Any details that i should be careful?
0 · Reply
EZ904Duval
EZ904Duval Dec. 14 at 1:55 AM
$BTMD Consensus price target range: roughly $4.5 – $6.0 (12-mo) 📊 Analyst sentiment: leans bullish/moderate Buy, but with variation and some Hold/Sell ratings in certain compilations
0 · Reply
Shadetreeengineer
Shadetreeengineer Dec. 11 at 8:16 PM
$BTMD looking good!
0 · Reply
Shadetreeengineer
Shadetreeengineer Dec. 11 at 4:35 PM
$BTMD I made a miss type in my last post. I meant the 50 SMA, and we are all over it right now. a lot of distance to the 200. I really feel like the bottom is in. Stock price is deeply undervalued by fundamentals. Be patent, its a matter of time!
1 · Reply
Shadetreeengineer
Shadetreeengineer Dec. 10 at 2:34 PM
$BTMD got to break 200 day SMA, and then we are off to the races. We are close!
1 · Reply
Latest News on BTMD
biote Corp. (BTMD) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 7:41 PM EST - 2 months ago

biote Corp. (BTMD) Q3 2025 Earnings Call Transcript

Biote Reports Third Quarter 2025 Financial Results

Nov 5, 2025, 4:05 PM EST - 2 months ago

Biote Reports Third Quarter 2025 Financial Results

Biote Schedules Third Quarter 2025 Financial Results Release and Conference Call

Oct 22, 2025, 4:05 PM EDT - 2 months ago

Biote Schedules Third Quarter 2025 Financial Results Release and Conference Call

Suncrete Completes Oklahoma Acquisition

Oct 21, 2025, 4:30 PM EDT - 2 months ago

Suncrete Completes Oklahoma Acquisition

HYAC

SunTx Capital Partners' Portfolio Company, Suncrete, to Pursue Listing on the New York Stock Exchange through a Proposed Business Combination with Haymaker Acquisition Corp. 4

Oct 9, 2025, 7:49 PM EDT - 3 months ago

SunTx Capital Partners' Portfolio Company, Suncrete, to Pursue Listing on the New York Stock Exchange through a Proposed Business Combination with Haymaker Acquisition Corp. 4

HYAC ROAD

Restructuring At Biote Will Drive Greater Growth And Profitability

Sep 10, 2025, 12:23 PM EDT - 4 months ago

Restructuring At Biote Will Drive Greater Growth And Profitability

biote Corp. (BTMD) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 3:13 AM EDT - 5 months ago

biote Corp. (BTMD) Q2 2025 Earnings Call Transcript

Biote Reports Second Quarter 2025 Financial Results

Aug 6, 2025, 4:05 PM EDT - 5 months ago

Biote Reports Second Quarter 2025 Financial Results

Biote Schedules Second Quarter 2025 Financial Results Release and Conference Call

Jul 23, 2025, 4:05 PM EDT - 6 months ago

Biote Schedules Second Quarter 2025 Financial Results Release and Conference Call

Biote Names Rich Barrera to Board of Directors

Jun 9, 2025, 4:05 PM EDT - 7 months ago

Biote Names Rich Barrera to Board of Directors

biote Corp. (BTMD) Q1 2025 Earnings Call Transcript

May 11, 2025, 2:55 AM EDT - 8 months ago

biote Corp. (BTMD) Q1 2025 Earnings Call Transcript

Biote Reports First Quarter 2025 Financial Results

May 7, 2025, 4:05 PM EDT - 8 months ago

Biote Reports First Quarter 2025 Financial Results

Biote Schedules First Quarter 2025 Financial Results Release and Conference Call

Apr 23, 2025, 4:05 PM EDT - 9 months ago

Biote Schedules First Quarter 2025 Financial Results Release and Conference Call

Biote Announces Purchase of Shares by Directors and CEO

Mar 18, 2025, 5:30 PM EDT - 10 months ago

Biote Announces Purchase of Shares by Directors and CEO

biote Corp. (BTMD) Q4 2024 Earnings Call Transcript

Mar 12, 2025, 9:33 PM EDT - 10 months ago

biote Corp. (BTMD) Q4 2024 Earnings Call Transcript

Biote Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 12, 2025, 4:05 PM EDT - 10 months ago

Biote Reports Fourth Quarter and Full Year 2024 Financial Results

Biote Schedules Fourth Quarter and Full Year 2024 Financial Results Release and Conference Call

Feb 26, 2025, 4:05 PM EST - 11 months ago

Biote Schedules Fourth Quarter and Full Year 2024 Financial Results Release and Conference Call

Biote Announces CEO Retirement and Succession Plan

Jan 30, 2025, 4:10 PM EST - 1 year ago

Biote Announces CEO Retirement and Succession Plan

biote Corp. (BTMD) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 2:56 AM EST - 1 year ago

biote Corp. (BTMD) Q3 2024 Earnings Call Transcript

Biote Reports Third Quarter 2024 Financial Results

Nov 12, 2024, 4:05 PM EST - 1 year ago

Biote Reports Third Quarter 2024 Financial Results

Biote Schedules Third Quarter 2024 Financial Results Release and Conference Call

Oct 29, 2024, 4:05 PM EDT - 1 year ago

Biote Schedules Third Quarter 2024 Financial Results Release and Conference Call

biote Corp. (BTMD) Q2 2024 Earnings Call Transcript

Aug 10, 2024, 2:42 PM EDT - 1 year ago

biote Corp. (BTMD) Q2 2024 Earnings Call Transcript

Biote Reports Second Quarter 2024 Financial Results

Aug 8, 2024, 4:05 PM EDT - 1 year ago

Biote Reports Second Quarter 2024 Financial Results

Biote Schedules Second Quarter 2024 Financial Results Release and Conference Call

Jul 25, 2024, 4:05 PM EDT - 1 year ago

Biote Schedules Second Quarter 2024 Financial Results Release and Conference Call

Biote Announces $60 Million Agreement to Repurchase 8.3 Million Shares and Cancel Approximately 4.0 Million Earnout Shares

Jun 20, 2024, 4:45 PM EDT - 1 year ago

Biote Announces $60 Million Agreement to Repurchase 8.3 Million Shares and Cancel Approximately 4.0 Million Earnout Shares

biote Corp. (BTMD) Q1 2024 Earnings Call Transcript

May 9, 2024, 3:58 AM EDT - 1 year ago

biote Corp. (BTMD) Q1 2024 Earnings Call Transcript

Biote Reports First Quarter 2024 Financial Results

May 7, 2024, 4:05 PM EDT - 1 year ago

Biote Reports First Quarter 2024 Financial Results

Biote Announces Definitive Settlement with Founder

Apr 29, 2024, 4:05 PM EDT - 1 year ago

Biote Announces Definitive Settlement with Founder

Biote Schedules First Quarter 2024 Financial Results Release and Conference Call

Apr 23, 2024, 4:05 PM EDT - 1 year ago

Biote Schedules First Quarter 2024 Financial Results Release and Conference Call

This overlooked corner of women's health could be a $350 billion market opportunity

Mar 15, 2024, 2:33 PM EDT - 1 year ago

This overlooked corner of women's health could be a $350 billion market opportunity

PFE PGNY VTGN DARE

biote Corp. (BTMD) Q4 2023 Earnings Call Transcript

Mar 12, 2024, 7:45 PM EDT - 1 year ago

biote Corp. (BTMD) Q4 2023 Earnings Call Transcript

Biote Reports Fourth Quarter and Full Year 2023 Financial Results

Mar 12, 2024, 4:05 PM EDT - 1 year ago

Biote Reports Fourth Quarter and Full Year 2023 Financial Results

Biote Schedules Fourth Quarter and Full Year 2023 Financial Results Release and Conference Call

Feb 27, 2024, 4:05 PM EST - 2 years ago

Biote Schedules Fourth Quarter and Full Year 2023 Financial Results Release and Conference Call

Biote Announces Agreement to Resolve Litigation and Repurchase All of Founder's Shares

Feb 20, 2024, 4:05 PM EST - 2 years ago

Biote Announces Agreement to Resolve Litigation and Repurchase All of Founder's Shares

Biote Announces $20 Million Share Repurchase Authorization

Jan 25, 2024, 4:05 PM EST - 2 years ago

Biote Announces $20 Million Share Repurchase Authorization

Biote to Purchase Asteria Health

Jan 17, 2024, 4:05 PM EST - 2 years ago

Biote to Purchase Asteria Health

Biote Provides Preliminary 2023 Results and Initial 2024 Guidance

Jan 17, 2024, 4:05 PM EST - 2 years ago

Biote Provides Preliminary 2023 Results and Initial 2024 Guidance

Biote Names Robert Peterson as Chief Financial Officer

Jan 11, 2024, 4:05 PM EST - 2 years ago

Biote Names Robert Peterson as Chief Financial Officer

biote Should Keep Delivering Strong Growth

Nov 29, 2023, 11:34 PM EST - 2 years ago

biote Should Keep Delivering Strong Growth

Biote Reports Third Quarter 2023 Financial Results

Nov 7, 2023, 4:45 PM EST - 2 years ago

Biote Reports Third Quarter 2023 Financial Results

Biote Schedules Third Quarter 2023 Financial Results Release and Conference Call

Oct 24, 2023, 8:30 AM EDT - 2 years ago

Biote Schedules Third Quarter 2023 Financial Results Release and Conference Call

Biote Reports Second Quarter 2023 Financial Results

Aug 10, 2023, 4:30 PM EDT - 2 years ago

Biote Reports Second Quarter 2023 Financial Results

Biote Schedules Second Quarter 2023 Financial Results Release and Conference Call

Jul 27, 2023, 8:30 AM EDT - 2 years ago

Biote Schedules Second Quarter 2023 Financial Results Release and Conference Call

Biote Formalizes Commitment to Men's Hormone Health With Launch of New Men's Health Division

Jun 22, 2023, 7:00 AM EDT - 2 years ago

Biote Formalizes Commitment to Men's Hormone Health With Launch of New Men's Health Division

Biote Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to Warrants

Jun 8, 2023, 6:05 PM EDT - 2 years ago

Biote Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to Warrants

Biote Announces Pricing of Secondary Offering of Common Stock

Jun 5, 2023, 7:48 AM EDT - 2 years ago

Biote Announces Pricing of Secondary Offering of Common Stock

Biote to Participate at Upcoming Investor Conferences

May 31, 2023, 8:30 AM EDT - 2 years ago

Biote to Participate at Upcoming Investor Conferences

Biote Appoints Mary J. Puncochar as Chief Commercial Officer

May 30, 2023, 8:30 AM EDT - 2 years ago

Biote Appoints Mary J. Puncochar as Chief Commercial Officer

Biote Announces Commencement of Exchange Offer and Consent Solicitation Relating to Warrants

May 9, 2023, 5:21 PM EDT - 2 years ago

Biote Announces Commencement of Exchange Offer and Consent Solicitation Relating to Warrants

Biote Reports First Quarter 2023 Financial Results

May 9, 2023, 5:21 PM EDT - 2 years ago

Biote Reports First Quarter 2023 Financial Results

Shadetreeengineer
Shadetreeengineer Jan. 7 at 3:54 PM
$BTMD added to position
1 · Reply
CapnKrunch
CapnKrunch Jan. 2 at 3:40 PM
$BTMD This stock is hot garbage!
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 23 at 8:28 PM
$BTMD
0 · Reply
convicente
convicente Dec. 22 at 4:42 PM
$PFE $MRNA looks like biote is about to run $BTMD
0 · Reply
convicente
convicente Dec. 19 at 7:29 PM
$CGC i am out of this one. Tilray got me already in the past with RS. This one isn't going to catch me again. To much exposure in the same industry. Just entered $BTMD hormon industry
0 · Reply
convicente
convicente Dec. 19 at 6:19 PM
$BTMD looks Great Any details that i should be careful?
0 · Reply
EZ904Duval
EZ904Duval Dec. 14 at 1:55 AM
$BTMD Consensus price target range: roughly $4.5 – $6.0 (12-mo) 📊 Analyst sentiment: leans bullish/moderate Buy, but with variation and some Hold/Sell ratings in certain compilations
0 · Reply
Shadetreeengineer
Shadetreeengineer Dec. 11 at 8:16 PM
$BTMD looking good!
0 · Reply
Shadetreeengineer
Shadetreeengineer Dec. 11 at 4:35 PM
$BTMD I made a miss type in my last post. I meant the 50 SMA, and we are all over it right now. a lot of distance to the 200. I really feel like the bottom is in. Stock price is deeply undervalued by fundamentals. Be patent, its a matter of time!
1 · Reply
Shadetreeengineer
Shadetreeengineer Dec. 10 at 2:34 PM
$BTMD got to break 200 day SMA, and then we are off to the races. We are close!
1 · Reply
CapnKrunch
CapnKrunch Dec. 9 at 4:10 PM
$BTMD moving in the right direction
1 · Reply
glorrel
glorrel Dec. 2 at 5:52 PM
$BTMD cant even hit 20K volume anymore, sheeesh
0 · Reply
glorrel
glorrel Nov. 25 at 9:56 PM
$BTMD 😴
0 · Reply
glorrel
glorrel Nov. 20 at 5:22 PM
$BTMD red everyday
1 · Reply
onions86
onions86 Nov. 20 at 4:11 AM
$BTMD added again here
1 · Reply
glorrel
glorrel Nov. 19 at 8:01 PM
$BTMD 😴
0 · Reply
glorrel
glorrel Nov. 19 at 5:29 PM
$BTMD adding some
0 · Reply
Geckofarts31
Geckofarts31 Nov. 18 at 4:40 PM
$BTMD does anyone know why we are currently sitting on our 52 week lows? I can’t seem to dig up anything recently damning. I don’t get it.
1 · Reply
glorrel
glorrel Nov. 13 at 8:27 PM
$BTMD Red red ted redddd
0 · Reply
onions86
onions86 Nov. 12 at 1:04 AM
$BTMD don’t look now but we just had ourselves a Green Day
2 · Reply
Geckofarts31
Geckofarts31 Nov. 11 at 9:39 PM
$BTMD FDA gonna be removing black box warning labels on hormone replacement therapies. Could be very bullish for biote. https://podcasts.apple.com/us/podcast/consider-this-from-npr/id1503226625?i=1000736173386
2 · Reply
Geckofarts31
Geckofarts31 Nov. 11 at 4:53 PM
$BTMD some good volume and nice moves despite a lackluster market day. Maybe people are digesting their earnings report still. Let’s see if we can hold, continue climbing. The two 30K+ orders earlier definitely didn’t feel like retail.
0 · Reply